451 related articles for article (PubMed ID: 28545622)
1. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.
Harel Z; Chertow GM; Shah PS; Harel S; Dorian P; Yan AT; Saposnik G; Sood MM; Molnar AO; Perl J; Wald RM; Silver S; Wald R
Can J Cardiol; 2017 Jun; 33(6):737-746. PubMed ID: 28545622
[TBL] [Abstract][Full Text] [Related]
2. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
Van Der Meersch H; De Bacquer D; De Vriese AS
Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
[TBL] [Abstract][Full Text] [Related]
4. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
[TBL] [Abstract][Full Text] [Related]
5. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
[TBL] [Abstract][Full Text] [Related]
6. Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis.
Randhawa MS; Vishwanath R; Rai MP; Wang L; Randhawa AK; Abela G; Dhar G
JAMA Netw Open; 2020 Apr; 3(4):e202175. PubMed ID: 32250434
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies.
Liu G; Long M; Hu X; Hu CH; Liao XX; Du ZM; Dong YG
Medicine (Baltimore); 2015 Dec; 94(50):e2233. PubMed ID: 26683937
[TBL] [Abstract][Full Text] [Related]
8. Warfarin use and the risks of stroke and bleeding in hemodialysis patients with atrial fibrillation: A systematic review and a meta-analysis.
Li J; Wang L; Hu J; Xu G
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):706-13. PubMed ID: 26026205
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
10. Effect of Warfarin on Ischemic Stroke, Bleeding, and Mortality in Patients with Atrial Fibrillation Receiving Peritoneal Dialysis.
Phan D; Yang SJ; Shen AY; Lee MS
Am J Cardiovasc Drugs; 2019 Oct; 19(5):509-515. PubMed ID: 31016691
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis.
Wong CX; Odutayo A; Emdin CA; Kinnear NJ; Sun MT
Am J Cardiol; 2016 Jun; 117(12):1934-41. PubMed ID: 27237624
[TBL] [Abstract][Full Text] [Related]
12. Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
Yoon CY; Noh J; Jhee JH; Chang TI; Kang EW; Kee YK; Kim H; Park S; Yun HR; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Kim C; Yoo TH
Stroke; 2017 Sep; 48(9):2472-2479. PubMed ID: 28801476
[TBL] [Abstract][Full Text] [Related]
13. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
[TBL] [Abstract][Full Text] [Related]
14. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.
Romanelli RJ; Nolting L; Dolginsky M; Kym E; Orrico KB
Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):126-34. PubMed ID: 26812933
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis.
Zimmerman D; Sood MM; Rigatto C; Holden RM; Hiremath S; Clase CM
Nephrol Dial Transplant; 2012 Oct; 27(10):3816-22. PubMed ID: 23114904
[TBL] [Abstract][Full Text] [Related]
16. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
[TBL] [Abstract][Full Text] [Related]
17. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.
Chen HY; Ou SH; Huang CW; Lee PT; Chou KJ; Lin PC; Su YC
Clin Drug Investig; 2021 Apr; 41(4):341-351. PubMed ID: 33709339
[TBL] [Abstract][Full Text] [Related]
19. Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.
Bundhun PK; Soogund MZ; Teeluck AR; Pursun M; Bhurtu A; Huang WQ
BMC Cardiovasc Disord; 2017 Jan; 17(1):15. PubMed ID: 28056795
[TBL] [Abstract][Full Text] [Related]
20. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
